RXO Inc Financials
RXO Inc (RXO) reported $5.7B in revenue for fiscal year 2025, up 26.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue has rebounded, but thinner gross spreads and a larger overhead base still block RXO's path back to profit.
FY2025 produced$51M of operating cash flow despite a$100M net loss, so accounting earnings and cash are telling somewhat different stories. But free cash flow remained just below breakeven because reinvestment still consumed that inflow, and with only$17M of cash against$1.23B of receivables, day-to-day liquidity leans heavily on customer collections rather than cash on hand.
The recovery in sales did not restore the underlying economics: gross margin fell to
The balance sheet is not debt-heavy, with long-term debt of
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of RXO Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
RXO Inc has an operating margin of -1.4%, meaning the company loses $1 on every $100 of revenue. This results in a profitability score of 31/100. This is down from -1.2% the prior year.
RXO Inc's revenue surged 26.2% year-over-year to $5.7B, reflecting rapid business expansion. This strong growth earns a score of 82/100.
RXO Inc has elevated debt relative to equity (D/E of 0.25), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 5/100, reflecting increased financial risk.
RXO Inc's current ratio of 1.27 indicates adequate short-term liquidity, earning a score of 32/100. The company can meet its near-term obligations, though with limited headroom.
While RXO Inc generated $51.0M in operating cash flow, capex of $59.0M consumed most of it, leaving -$8.0M in free cash flow. This results in a low score of 28/100, reflecting heavy capital investment rather than weak cash generation.
RXO Inc posts a -6.5% return on equity (ROE), meaning it loses $6 for every $100 of shareholders' equity. This results in a returns score of 30/100. This is up from -18.0% the prior year.
RXO Inc scores 2.90, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
RXO Inc passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
RXO Inc reported a net loss of $100.0M while generating $51.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
RXO Inc generated $5.7B in revenue in fiscal year 2025. This represents an increase of 26.2% from the prior year.
RXO Inc's EBITDA was $37.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 19.4% from the prior year.
RXO Inc reported -$100.0M in net income in fiscal year 2025. This represents an increase of 65.5% from the prior year.
RXO Inc earned -$0.59 per diluted share (EPS) in fiscal year 2025. This represents an increase of 72.8% from the prior year.
Cash & Balance Sheet
RXO Inc recorded an outflow of $8.0M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 86.0% from the prior year.
RXO Inc held $17.0M in cash against $387.0M in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
RXO Inc's gross margin was 19.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.9 percentage points from the prior year.
RXO Inc's operating margin was -1.4% in fiscal year 2025, reflecting core business profitability. This is down 0.1 percentage points from the prior year.
RXO Inc's net profit margin was -1.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.6 percentage points from the prior year.
RXO Inc's ROE was -6.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 11.5 percentage points from the prior year.
Capital Allocation
RXO Inc repurchased no shares in fiscal year 2025.
RXO Inc invested $59.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 31.1% from the prior year.
Not reported for fiscal year 2025.
RXO Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|---|
| Revenue | $6.1B | $5.7B+26.2% | $4.5B+15.9% | $3.9B-18.1% | $4.8B+2.3% | $4.7B+39.7% | $3.4B |
| Cost of Revenue | $5.0B | $4.6B+29.3% | $3.6B+20.2% | $3.0B-18.1% | $3.6B-1.5% | $3.7B+43.3% | $2.6B |
| Gross Profit | $1.1B | $1.1B+14.8% | $985.0M+2.6% | $960.0M-18.1% | $1.2B+16.3% | $1.0B+27.8% | $789.0M |
| SG&A Expenses | $816.0M | $832.0M+24.9% | $666.0M+12.7% | $591.0M-7.7% | $640.0M+18.7% | $539.0M+18.5% | $455.0M |
| Operating Income | -$76.0M | -$79.0M-41.1% | -$56.0M-243.6% | $39.0M-68.3% | $123.0M-35.9% | $192.0M+220.0% | $60.0M |
| Income Tax | -$18.0M | -$15.0M-7.1% | -$14.0M | $0-100.0% | $27.0M-34.1% | $41.0M+192.9% | $14.0M |
| Net Income | -$105.0M | -$100.0M+65.5% | -$290.0M-7350.0% | $4.0M-95.7% | $92.0M-38.7% | $150.0M+248.8% | $43.0M |
| EPS (Diluted) | — | -$0.59+72.8% | -$2.17-7333.3% | $0.03-96.2% | $0.79-39.2% | $1.30+251.4% | $0.37 |
Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
RXO Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|
| Total Assets | $3.3B-4.0% | $3.4B+87.1% | $1.8B-10.1% | $2.0B-1.8% | $2.1B | N/A |
| Current Assets | $1.3B-1.6% | $1.3B+68.2% | $796.0M-22.6% | $1.0B-5.0% | $1.1B | N/A |
| Cash & Equivalents | $17.0M-51.4% | $35.0M+600.0% | $5.0M-94.9% | $98.0M+237.9% | $29.0M-58.6% | $70.0M |
| Accounts Receivable | $1.2B-0.1% | $1.2B+65.1% | $743.0M-17.4% | $900.0M-10.9% | $1.0B | N/A |
| Goodwill | $1.1B-1.1% | $1.1B+78.3% | $630.0M0.0% | $630.0M0.0% | $630.0M | N/A |
| Total Liabilities | $1.7B-3.7% | $1.8B+46.4% | $1.2B-14.8% | $1.4B+44.7% | $998.0M | N/A |
| Current Liabilities | $1.0B-2.5% | $1.1B+56.2% | $682.0M-17.1% | $823.0M+0.9% | $816.0M | N/A |
| Long-Term Debt | $387.0M+10.3% | $351.0M-1.4% | $356.0M-21.1% | $451.0M | $0 | N/A |
| Total Equity | $1.5B-4.4% | $1.6B+171.4% | $594.0M+1.2% | $587.0M-45.1% | $1.1B+0.2% | $1.1B |
| Retained Earnings | -$384.0M-35.2% | -$284.0M-4833.3% | $6.0M+200.0% | $2.0M | $0 | N/A |
Not reported in any period shown, so not listed: Inventory.
RXO Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$17.0M | $51.0M+525.0% | -$12.0M-113.5% | $89.0M-71.3% | $310.0M+100.0% | $155.0M+520.0% | $25.0M |
| Capital Expenditures | $59.0M | $59.0M+31.1% | $45.0M-29.7% | $64.0M+12.3% | $57.0M+46.2% | $39.0M-17.0% | $47.0M |
| Free Cash Flow | -$76.0M | -$8.0M+86.0% | -$57.0M-328.0% | $25.0M-90.1% | $253.0M+118.1% | $116.0M+627.3% | -$22.0M |
| Investing Cash Flow | -$57.0M | -$71.0M+93.3% | -$1.1B-1512.1% | -$66.0M-17.9% | -$56.0M-47.4% | -$38.0M+2.6% | -$39.0M |
| Financing Cash Flow | $71.0M | $1.0M-99.9% | $1.1B+1047.0% | -$117.0M+36.1% | -$183.0M-15.8% | -$158.0M-593.8% | $32.0M |
| Share Buybacks | N/A | $0 | $0-100.0% | $2.0M | $0 | $0 | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
RXO Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 |
|---|---|---|---|---|---|---|
| Gross Margin | 19.7%-1.9pp | 21.6%-2.8pp | 24.4%0.0pp | 24.4%+2.9pp | 21.5%-2.0pp | 23.5% |
| Operating Margin | -1.4%-0.1pp | -1.2%-2.2pp | 1.0%-1.6pp | 2.6%-1.5pp | 4.1%+2.3pp | 1.8% |
| Net Margin | -1.7%+4.6pp | -6.4%-6.5pp | 0.1%-1.8pp | 1.9%-1.3pp | 3.2%+1.9pp | 1.3% |
| Return on Equity | -6.5%+11.5pp | -18.0%-18.7pp | 0.7%-15.0pp | 15.7%+1.7pp | 14.0%+10.0pp | 4.0% |
| Return on Assets | -3.0%+5.4pp | -8.5%-8.7pp | 0.2%-4.3pp | 4.5%-2.7pp | 7.2% | N/A |
| Current Ratio | 1.270.0x | 1.26+0.1x | 1.17-0.1x | 1.25-0.1x | 1.33 | N/A |
| Debt-to-Equity | 0.250.0x | 0.22-0.4x | 0.60-0.2x | 0.77+0.8x | 0.00 | N/A |
| FCF Margin | -0.1%+1.1pp | -1.3%-1.9pp | 0.6%-4.6pp | 5.3%+2.8pp | 2.5%+3.1pp | -0.7% |
Similar Companies
Where RXO Inc Ranks
Frequently Asked Questions
What is RXO Inc's annual revenue?
RXO Inc (RXO) reported $5.7B in total revenue for fiscal year 2025. This represents a 26.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is RXO Inc's revenue growing?
RXO Inc (RXO) revenue grew by 26.2% year-over-year, from $4.5B to $5.7B in fiscal year 2025.
Is RXO Inc profitable?
No, RXO Inc (RXO) reported a net income of -$100.0M in fiscal year 2025, with a net profit margin of -1.7%.
What is RXO Inc's EBITDA?
RXO Inc (RXO) had EBITDA of $37.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does RXO Inc have?
As of fiscal year 2025, RXO Inc (RXO) had $17.0M in cash and equivalents against $387.0M in long-term debt.
What is RXO Inc's gross margin?
RXO Inc (RXO) had a gross margin of 19.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is RXO Inc's operating margin?
RXO Inc (RXO) had an operating margin of -1.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is RXO Inc's net profit margin?
RXO Inc (RXO) had a net profit margin of -1.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is RXO Inc's return on equity (ROE)?
RXO Inc (RXO) has a return on equity of -6.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is RXO Inc's free cash flow?
RXO Inc (RXO) recorded an outflow of $8.0M in free cash flow during fiscal year 2025. This represents a 86.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is RXO Inc's operating cash flow?
RXO Inc (RXO) generated $51.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are RXO Inc's total assets?
RXO Inc (RXO) had $3.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are RXO Inc's capital expenditures?
RXO Inc (RXO) invested $59.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is RXO Inc's current ratio?
RXO Inc (RXO) had a current ratio of 1.27 as of fiscal year 2025, which is considered adequate.
What is RXO Inc's debt-to-equity ratio?
RXO Inc (RXO) had a debt-to-equity ratio of 0.25 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is RXO Inc's return on assets (ROA)?
RXO Inc (RXO) had a return on assets of -3.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is RXO Inc's Altman Z-Score?
RXO Inc (RXO) has an Altman Z-Score of 2.90, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is RXO Inc's Piotroski F-Score?
RXO Inc (RXO) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are RXO Inc's earnings high quality?
RXO Inc (RXO) reported a net loss of $100.0M while generating $51.0M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is RXO Inc?
RXO Inc (RXO) scores 35 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.